These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2982715)

  • 1. An ultrastructural comparison of mesotheliomas with adenocarcinomas of the lung and breast.
    Warhol MJ; Corson JM
    Hum Pathol; 1985 Jan; 16(1):50-5. PubMed ID: 2982715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
    Warhol MJ; Hickey WF; Corson JM
    Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ultrastructural comparison of mesotheliomas and adenocarcinomas of the ovary and endometrium.
    Warhol MJ; Hunter NJ; Corson JM
    Int J Gynecol Pathol; 1982; 1(2):125-34. PubMed ID: 6892219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
    Sakuma N; Kamei T; Ishihara T
    Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
    Hammar SP; Bockus DE; Remington FL; Rohrbach KA
    Ultrastruct Pathol; 1996; 20(4):293-325. PubMed ID: 8837337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.
    Dewar A; Valente M; Ring NP; Corrin B
    J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ultrastructure of metastatic adenocarcinoma in serous fluids. An aid in identification of the primary site of the neoplasm.
    Hanna W; Kahn HJ
    Acta Cytol; 1985; 29(3):202-10. PubMed ID: 3859120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas.
    Foster MR; Johnson JE; Olson SJ; Allred DC
    Arch Pathol Lab Med; 2001 Oct; 125(10):1316-20. PubMed ID: 11570906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases.
    Otis CN; Carter D; Cole S; Battifora H
    Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural histochemistry of mesotheliomas and adenocarcinomas in malignant effusions.
    Barsotti P; Muda AO; Ascoli V; Casareale P; Nardi F
    Diagn Cytopathol; 1989; 5(2):154-61. PubMed ID: 2776597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scanning electron microscopic distinction of pleural mesotheliomas from adenocarcinomas.
    Jandik WR; Landas SK; Bray CK; Lager DJ
    Mod Pathol; 1993 Nov; 6(6):761-4. PubMed ID: 8302820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.
    Wick MR; Loy T; Mills SE; Legier JF; Manivel JC
    Hum Pathol; 1990 Jul; 21(7):759-66. PubMed ID: 2193875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T
    Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas.
    Dahlstrom JE; Maxwell LE; Brodie N; Zardawi IM; Jain S
    Pathology; 2001 Aug; 33(3):287-91. PubMed ID: 11523926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
    Blobel GA; Moll R; Franke WW; Kayser KW; Gould VE
    Am J Pathol; 1985 Nov; 121(2):235-47. PubMed ID: 2414994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructure of poorly differentiated diffuse epithelial mesotheliomas.
    Dardick I; Al-Jabi M; McCaughey WT; Srigley JR; van Nostrand AW; Ritchie AC
    Ultrastruct Pathol; 1984; 7(2-3):151-60. PubMed ID: 6085430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.
    Han AC; Peralta-Soler A; Knudsen KA; Wheelock MJ; Johnson KR; Salazar H
    Hum Pathol; 1997 Jun; 28(6):641-5. PubMed ID: 9190996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.
    Ordóñez NG
    Am J Clin Pathol; 1998 Jan; 109(1):85-9. PubMed ID: 9426522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.